SAT-021 Effects of E2/P4 Oral Capsules on Bone Turnover in Women with Vasomotor Symptoms

Menopausal hormone therapy slows bone turnover and reduces the risk of osteoporotic fractures. The objective of this post hoc analysis was to evaluate bone turnover markers (BTM) in the phase 3 REPLENISH trial, which evaluated vasomotor symptoms (VMS) with an oral estradiol/progesterone (E2/P4) in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Constantine, Ginger, McClung, Michael R, Kagan, Risa, Graham, Shelli, Bernick, Brian, Mirkin, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208564/
http://dx.doi.org/10.1210/jendso/bvaa046.536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208564/
http://dx.doi.org/10.1210/jendso/bvaa046.536

Ejemplares similares